Biogen To Buy Human Immunology Biosciences In Deal Valued At

Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

WESTON (dpa-AFX) - Biogen Inc. (BIIB) and privately-held biotechnology company Human Immunology Biosciences or HI-Bio, announced Wednesday the companies have entered into a definitive agreement

Related Keywords

, Biogen Inc , Human Immunology Biosciences , Human Immunology Bioscience , San Francisco Bay Area , Ihr Portfolio ,

© 2025 Vimarsana